UC San Francisco (UCSF) has launched a collaboration with international pharmaceutical company GlaxoSmithKline plc (GSK) to promote early-stage research with the potential to translate into new therapies for cancer, obesity and antibiotic resistant bacteria.
Through the collaboration, researchers from UCSF will work alongside GSK scientists to identify and jointly expedite promising basic research. In a shift from traditional sponsored-research agreements, the program will provide early-stage funding for validating academic discoveries that are not otherwise supported by traditional grant mechanisms.
{iframe}https://www.ucsf.edu/news/2015/10/136646/ucsf-and-gsk-launch-new-collaborative-research-model{/iframe}